Verrica Pharmaceuticals Inc (VRCA)
1.44
-0.09
(-5.88%)
USD |
NASDAQ |
Nov 04, 16:00
1.05
-0.39
(-27.08%)
After-Hours: 20:00
Verrica Pharmaceuticals Profit Margin (Quarterly): -332.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -332.0% |
| March 31, 2024 | -531.4% |
| December 31, 2023 | -1.24K% |
| September 30, 2023 | -850.3% |
| June 30, 2023 | -6.04K% |
| March 31, 2023 | -17.81K% |
| December 31, 2022 | -8.72K% |
| Date | Value |
|---|---|
| September 30, 2022 | 1.00% |
| June 30, 2022 | -4.75K% |
| March 31, 2022 | -1.97K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -7.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.81K%
Minimum
Mar 2023
1.00%
Maximum
Sep 2022
-3.84K%
Average
-1.24K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Elite Pharmaceuticals Inc | 3.27% |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | -78.30% |
| Terns Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -411.3% |
| Return on Assets | -121.0% |
| Return on Invested Capital | -157.2% |
| Gross Profit Margin (Quarterly) | 89.53% |
| Operating Margin (Quarterly) | -293.7% |
| Return on Net Operating Assets | -787.7% |